カテゴリー： 世界, 医療/バイオ, Allied Market Research

世界の血栓溶解薬市場2023年-2032年：製品別（血栓溶解薬、抗血小板薬、抗凝固薬、その他）、疾患別（肺塞栓症、深部静脈血栓症、心房細動、その他）、投与経路別（経口、注射）、流通チャネル別（病院薬局、オンライン薬局、小売薬局）

【英語タイトル】Clot Busting Drugs Market By Product (Thrombolytic Drugs, Anti-Platelet Drugs, Anticoagulants, Others), By Indication (Pulmonary Embolism, Deep Vein Thrombosis, Atrial Fibrillation, Others), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy): Global Opportunity Analysis and Industry Forecast, 2023-2032

Allied Market Researchが出版した調査資料（ALD23SEP170）・商品コード：ALD23SEP170
・発行会社（調査会社）：Allied Market Research
・発行日：2023年6月
・ページ数：280
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後24時間以内）
・調査対象地域：グローバル
・産業分野：生命科学
◆販売価格オプション（消費税別）
Online Only（1名閲覧、印刷不可）USD3,570 ⇒換算￥542,640見積依頼/購入/質問フォーム
Single User（1名閲覧）USD5,730 ⇒換算￥870,960見積依頼/購入/質問フォーム
Enterprise User（閲覧人数無制限）USD9,600 ⇒換算￥1,459,200見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

血栓溶解薬の世界市場は、2023年から2032年までの年平均成長率8.2%で、2022年の286億1,640万ドルから成長し、2032年には600億9,920万ドルに達すると予測されています。血栓溶解薬は、血栓溶解剤または線溶薬としても知られ、血栓症と呼ばれる病状において血栓を溶解するために使用される薬剤です。血栓症は、血管内に血栓が形成され、血液の流れが阻害されることで起こります。TPAは、血栓溶解薬または血栓破壊薬であり、脳への血液の流れに閉塞や障害を引き起こしている血栓を分解し、脳の患部への血流の回復を助けるために使用されます。ヘパリン、ワルファリン、ダビガトラン、アピキサバン、リバーロキサバンなどの抗凝固薬は、血液をサラサラにして血栓の溶解を助ける薬です。

心血管疾患の治療ガイドラインでは、特定の病態において血栓溶解薬の使用が頻繁に必要とされています。診断方法が改善され、心血管疾患の徴候や症状に対する認識が高まったことで、早期発見・早期治療が可能になりました。将来的な危害を防ぐために、早期介入には通常、血栓溶解薬の使用が含まれます。全体として、心血管障害の有病率の上昇は、治療選択肢の革新と意識の高まりと相まって、血栓溶解薬の需要を押し上げています。

尿や便の異常出血、傷口や切り傷からの過度の出血、血栓溶解薬に対するアレルギー反応、低血圧、血栓溶解薬のその他の副作用のため、慎重かつ管理された投与が必要です。まれに、血栓溶解薬を使用せずに血栓をコントロールする他の選択肢がある場合があります。例えば、深部静脈血栓症や肺塞栓症の場合、抗凝固薬（ヘパリンや直接経口抗凝固薬など）が主な治療薬として使用されることがあります。補完療法が利用できるかどうかは、血栓溶解薬の需要に影響を与える可能性があります。

血栓溶解薬市場の拡大は、経済成長、医療保険の増加、医療意識の高まりなど、さまざまな要因によってもたらされます。医療費の増加に伴い、血栓溶解薬はより手頃な価格で入手できるようになり、その結果需要が増加します。血栓溶解薬の有効性と安全性を評価するための継続的な研究と臨床試験が市場の拡大を後押ししています。医療インフラが改善し、さまざまな地域で血栓障害に対する認識が高まるにつれて、効果的な血栓溶解薬に対するニーズが高まっています。製薬会社は、手頃な価格で利用しやすい治療法を提供することで、こうした市場を開拓することができます。

COVID-19の流行は、血栓溶解薬市場を含む医療の多くの部分に大きな影響を与えています。COVID-19は主に呼吸器系に影響を及ぼしますが、さまざまな心血管系の問題を引き起こす可能性もあり、血栓溶解薬の需要や使用に影響を与える可能性があります。COVID-19は、深部静脈血栓症（DVT）、肺塞栓症、脳卒中などの障害を引き起こす可能性のある血栓形成の高いリスクと関連しています。研究では、COVID-19に関連する血栓形成の問題に対する、血栓溶解薬を含むさまざまな抗凝固療法の有効性が検討されています。これらの研究は、パンデミック後の市場ダイナミクスや臨床実践に影響を与えると予想されます。
本レポートでは、Pfizer Inc., Johnson & Johnson Services Inc, Sanofi, Dr. Reddy’s Laboratories, Bayer AG, Boehringer Ingelheim Gmbh, Genentech Inc., Eli Lilly and Company, Sun Pharmaceutical Industries Ltd., and Merck & Co.などの主要企業を紹介しています。

ステークホルダーにとっての主なメリット
本レポートは、2022年から2032年までの血栓溶解薬市場分析の市場セグメント、現在の動向、予測、ダイナミクスを定量的に分析し、血栓溶解薬の市場機会を特定します。
主要な促進要因、阻害要因、機会に関する情報とともに市場調査を提供します。
ポーターのファイブフォース分析により、バイヤーとサプライヤーの潜在力を明らかにし、ステークホルダーが利益重視のビジネス決定を下し、サプライヤーとバイヤーのネットワークを強化できるようにします。
血栓溶解薬市場のセグメンテーションを詳細に分析することで、市場機会を見極めることができます。
各地域の主要国を世界市場への収益貢献度に応じてマッピングしています。
市場プレイヤーのポジショニングはベンチマーキングを容易にし、市場プレイヤーの現在のポジションを明確に理解することができます。
血栓溶解薬の地域別および世界市場動向、主要企業、市場セグメント、応用分野、市場成長戦略の分析を含みます。

主要市場セグメント
製品別
血栓溶解薬
抗血小板薬
抗凝固薬
その他

適応症別
深部静脈血栓症
心房細動
その他
肺塞栓症

投与経路別
経口剤
注射剤

流通経路別
病院薬局
オンライン薬局
小売薬局

地域別
北米
アメリカ
カナダ
メキシコ
ヨーロッパ
ドイツ
イギリス
フランス
スペイン
イタリア
その他のヨーロッパ
アジア太平洋
中国
日本
インド
韓国
オーストラリア
その他のアジア太平洋地域
LAMEA
ブラジル
サウジアラビア
アラブ首長国連邦
南アフリカ
その他の地域

主要市場プレイヤー
○ Bayer AG
○ Boehringer Ingelheim Gmbh
○ Dr. Reddy’s Laboratories
○ Eli Lilly and Company
○ Genentech Inc.
○ Johnson & Johnson Services Inc
○ Merck & Co
○ Pfizer Inc.
○ Sanofi
○ Sun Pharmaceutical Industries Ltd.

第1章：イントロダクション
第2章：エグゼクティブサマリー
第3章：市場概要
第4章：血栓溶解薬市場、製品別
第5章：血栓溶解薬市場、疾患別
第6章：血栓溶解薬市場、投与経路別
第7章：血栓溶解薬市場、流通チャネル別
第8章：血栓溶解薬市場、地域別
第9章：競争状況
第10章：企業情報

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.5. COVID-19 Impact Analysis on the market
3.6. Average Selling Price
3.7. Market Share Analysis
3.8. Brand Share Analysis
3.9. Value Chain Analysis
3.10. Key Regulation Analysis
3.11. Patent Landscape
3.12. Regulatory Guidelines
3.13. Trade Data Analysis
CHAPTER 4: CLOT BUSTING DRUGS MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Thrombolytic Drugs
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Anti-Platelet Drugs
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Anticoagulants
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
4.5. Others
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market share analysis by country
CHAPTER 5: CLOT BUSTING DRUGS MARKET, BY INDICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Pulmonary Embolism
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Deep Vein Thrombosis
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Atrial Fibrillation
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Others
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
CHAPTER 6: CLOT BUSTING DRUGS MARKET, BY ROUTE OF ADMINISTRATION
6.1. Overview
6.1.1. Market size and forecast
6.2. Oral
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Injectable
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
CHAPTER 7: CLOT BUSTING DRUGS MARKET, BY DISTRIBUTION CHANNEL
7.1. Overview
7.1.1. Market size and forecast
7.2. Hospital Pharmacy
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by region
7.2.3. Market share analysis by country
7.3. Online Pharmacy
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by region
7.3.3. Market share analysis by country
7.4. Retail Pharmacy
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by region
7.4.3. Market share analysis by country
CHAPTER 8: CLOT BUSTING DRUGS MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast By Region
8.2. North America
8.2.1. Key trends and opportunities
8.2.2. Market size and forecast, by Product
8.2.3. Market size and forecast, by Indication
8.2.4. Market size and forecast, by Route of Administration
8.2.5. Market size and forecast, by Distribution Channel
8.2.6. Market size and forecast, by country
8.2.6.1. U.S.
8.2.6.1.1. Key market trends, growth factors and opportunities
8.2.6.1.2. Market size and forecast, by Product
8.2.6.1.3. Market size and forecast, by Indication
8.2.6.1.4. Market size and forecast, by Route of Administration
8.2.6.1.5. Market size and forecast, by Distribution Channel
8.2.6.2. Canada
8.2.6.2.1. Key market trends, growth factors and opportunities
8.2.6.2.2. Market size and forecast, by Product
8.2.6.2.3. Market size and forecast, by Indication
8.2.6.2.4. Market size and forecast, by Route of Administration
8.2.6.2.5. Market size and forecast, by Distribution Channel
8.2.6.3. Mexico
8.2.6.3.1. Key market trends, growth factors and opportunities
8.2.6.3.2. Market size and forecast, by Product
8.2.6.3.3. Market size and forecast, by Indication
8.2.6.3.4. Market size and forecast, by Route of Administration
8.2.6.3.5. Market size and forecast, by Distribution Channel
8.3. Europe
8.3.1. Key trends and opportunities
8.3.2. Market size and forecast, by Product
8.3.3. Market size and forecast, by Indication
8.3.4. Market size and forecast, by Route of Administration
8.3.5. Market size and forecast, by Distribution Channel
8.3.6. Market size and forecast, by country
8.3.6.1. Germany
8.3.6.1.1. Key market trends, growth factors and opportunities
8.3.6.1.2. Market size and forecast, by Product
8.3.6.1.3. Market size and forecast, by Indication
8.3.6.1.4. Market size and forecast, by Route of Administration
8.3.6.1.5. Market size and forecast, by Distribution Channel
8.3.6.2. UK
8.3.6.2.1. Key market trends, growth factors and opportunities
8.3.6.2.2. Market size and forecast, by Product
8.3.6.2.3. Market size and forecast, by Indication
8.3.6.2.4. Market size and forecast, by Route of Administration
8.3.6.2.5. Market size and forecast, by Distribution Channel
8.3.6.3. France
8.3.6.3.1. Key market trends, growth factors and opportunities
8.3.6.3.2. Market size and forecast, by Product
8.3.6.3.3. Market size and forecast, by Indication
8.3.6.3.4. Market size and forecast, by Route of Administration
8.3.6.3.5. Market size and forecast, by Distribution Channel
8.3.6.4. Spain
8.3.6.4.1. Key market trends, growth factors and opportunities
8.3.6.4.2. Market size and forecast, by Product
8.3.6.4.3. Market size and forecast, by Indication
8.3.6.4.4. Market size and forecast, by Route of Administration
8.3.6.4.5. Market size and forecast, by Distribution Channel
8.3.6.5. Italy
8.3.6.5.1. Key market trends, growth factors and opportunities
8.3.6.5.2. Market size and forecast, by Product
8.3.6.5.3. Market size and forecast, by Indication
8.3.6.5.4. Market size and forecast, by Route of Administration
8.3.6.5.5. Market size and forecast, by Distribution Channel
8.3.6.6. Rest of Europe
8.3.6.6.1. Key market trends, growth factors and opportunities
8.3.6.6.2. Market size and forecast, by Product
8.3.6.6.3. Market size and forecast, by Indication
8.3.6.6.4. Market size and forecast, by Route of Administration
8.3.6.6.5. Market size and forecast, by Distribution Channel
8.4. Asia-Pacific
8.4.1. Key trends and opportunities
8.4.2. Market size and forecast, by Product
8.4.3. Market size and forecast, by Indication
8.4.4. Market size and forecast, by Route of Administration
8.4.5. Market size and forecast, by Distribution Channel
8.4.6. Market size and forecast, by country
8.4.6.1. China
8.4.6.1.1. Key market trends, growth factors and opportunities
8.4.6.1.2. Market size and forecast, by Product
8.4.6.1.3. Market size and forecast, by Indication
8.4.6.1.4. Market size and forecast, by Route of Administration
8.4.6.1.5. Market size and forecast, by Distribution Channel
8.4.6.2. Japan
8.4.6.2.1. Key market trends, growth factors and opportunities
8.4.6.2.2. Market size and forecast, by Product
8.4.6.2.3. Market size and forecast, by Indication
8.4.6.2.4. Market size and forecast, by Route of Administration
8.4.6.2.5. Market size and forecast, by Distribution Channel
8.4.6.3. India
8.4.6.3.1. Key market trends, growth factors and opportunities
8.4.6.3.2. Market size and forecast, by Product
8.4.6.3.3. Market size and forecast, by Indication
8.4.6.3.4. Market size and forecast, by Route of Administration
8.4.6.3.5. Market size and forecast, by Distribution Channel
8.4.6.4. South Korea
8.4.6.4.1. Key market trends, growth factors and opportunities
8.4.6.4.2. Market size and forecast, by Product
8.4.6.4.3. Market size and forecast, by Indication
8.4.6.4.4. Market size and forecast, by Route of Administration
8.4.6.4.5. Market size and forecast, by Distribution Channel
8.4.6.5. Australia
8.4.6.5.1. Key market trends, growth factors and opportunities
8.4.6.5.2. Market size and forecast, by Product
8.4.6.5.3. Market size and forecast, by Indication
8.4.6.5.4. Market size and forecast, by Route of Administration
8.4.6.5.5. Market size and forecast, by Distribution Channel
8.4.6.6. Rest of Asia-Pacific
8.4.6.6.1. Key market trends, growth factors and opportunities
8.4.6.6.2. Market size and forecast, by Product
8.4.6.6.3. Market size and forecast, by Indication
8.4.6.6.4. Market size and forecast, by Route of Administration
8.4.6.6.5. Market size and forecast, by Distribution Channel
8.5. LAMEA
8.5.1. Key trends and opportunities
8.5.2. Market size and forecast, by Product
8.5.3. Market size and forecast, by Indication
8.5.4. Market size and forecast, by Route of Administration
8.5.5. Market size and forecast, by Distribution Channel
8.5.6. Market size and forecast, by country
8.5.6.1. Brazil
8.5.6.1.1. Key market trends, growth factors and opportunities
8.5.6.1.2. Market size and forecast, by Product
8.5.6.1.3. Market size and forecast, by Indication
8.5.6.1.4. Market size and forecast, by Route of Administration
8.5.6.1.5. Market size and forecast, by Distribution Channel
8.5.6.2. Saudi Arabia
8.5.6.2.1. Key market trends, growth factors and opportunities
8.5.6.2.2. Market size and forecast, by Product
8.5.6.2.3. Market size and forecast, by Indication
8.5.6.2.4. Market size and forecast, by Route of Administration
8.5.6.2.5. Market size and forecast, by Distribution Channel
8.5.6.3. United Arab Emirates
8.5.6.3.1. Key market trends, growth factors and opportunities
8.5.6.3.2. Market size and forecast, by Product
8.5.6.3.3. Market size and forecast, by Indication
8.5.6.3.4. Market size and forecast, by Route of Administration
8.5.6.3.5. Market size and forecast, by Distribution Channel
8.5.6.4. South Africa
8.5.6.4.1. Key market trends, growth factors and opportunities
8.5.6.4.2. Market size and forecast, by Product
8.5.6.4.3. Market size and forecast, by Indication
8.5.6.4.4. Market size and forecast, by Route of Administration
8.5.6.4.5. Market size and forecast, by Distribution Channel
8.5.6.5. Rest of LAMEA
8.5.6.5.1. Key market trends, growth factors and opportunities
8.5.6.5.2. Market size and forecast, by Product
8.5.6.5.3. Market size and forecast, by Indication
8.5.6.5.4. Market size and forecast, by Route of Administration
8.5.6.5.5. Market size and forecast, by Distribution Channel
CHAPTER 9: COMPETITIVE LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Top player positioning, 2022
CHAPTER 10: COMPANY PROFILES
10.1. Pfizer Inc.
10.1.1. Company overview
10.1.2. Key Executives
10.1.3. Company snapshot
10.2. Johnson & Johnson Services Inc
10.2.1. Company overview
10.2.2. Key Executives
10.2.3. Company snapshot
10.3. Sanofi
10.3.1. Company overview
10.3.2. Key Executives
10.3.3. Company snapshot
10.4. Dr. Reddy’s Laboratories
10.4.1. Company overview
10.4.2. Key Executives
10.4.3. Company snapshot
10.5. Bayer AG
10.5.1. Company overview
10.5.2. Key Executives
10.5.3. Company snapshot
10.6. Boehringer Ingelheim Gmbh
10.6.1. Company overview
10.6.2. Key Executives
10.6.3. Company snapshot
10.7. Genentech Inc.
10.7.1. Company overview
10.7.2. Key Executives
10.7.3. Company snapshot
10.8. Eli Lilly and Company
10.8.1. Company overview
10.8.2. Key Executives
10.8.3. Company snapshot
10.9. Sun Pharmaceutical Industries Ltd.
10.9.1. Company overview
10.9.2. Key Executives
10.9.3. Company snapshot
10.10. Merck & Co
10.10.1. Company overview
10.10.2. Key Executives
10.10.3. Company snapshot

LIST OF TABLES
TABLE 01. GLOBAL CLOT BUSTING DRUGS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 02. CLOT BUSTING DRUGS MARKET FOR THROMBOLYTIC DRUGS, BY REGION, 2022-2032 ($MILLION)
TABLE 03. CLOT BUSTING DRUGS MARKET FOR ANTI-PLATELET DRUGS, BY REGION, 2022-2032 ($MILLION)
TABLE 04. CLOT BUSTING DRUGS MARKET FOR ANTICOAGULANTS, BY REGION, 2022-2032 ($MILLION)
TABLE 05. CLOT BUSTING DRUGS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 06. GLOBAL CLOT BUSTING DRUGS MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 07. CLOT BUSTING DRUGS MARKET FOR PULMONARY EMBOLISM, BY REGION, 2022-2032 ($MILLION)
TABLE 08. CLOT BUSTING DRUGS MARKET FOR DEEP VEIN THROMBOSIS, BY REGION, 2022-2032 ($MILLION)
TABLE 09. CLOT BUSTING DRUGS MARKET FOR ATRIAL FIBRILLATION, BY REGION, 2022-2032 ($MILLION)
TABLE 10. CLOT BUSTING DRUGS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 11. GLOBAL CLOT BUSTING DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
TABLE 12. CLOT BUSTING DRUGS MARKET FOR ORAL, BY REGION, 2022-2032 ($MILLION)
TABLE 13. CLOT BUSTING DRUGS MARKET FOR INJECTABLE, BY REGION, 2022-2032 ($MILLION)
TABLE 14. GLOBAL CLOT BUSTING DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 15. CLOT BUSTING DRUGS MARKET FOR HOSPITAL PHARMACY, BY REGION, 2022-2032 ($MILLION)
TABLE 16. CLOT BUSTING DRUGS MARKET FOR ONLINE PHARMACY, BY REGION, 2022-2032 ($MILLION)
TABLE 17. CLOT BUSTING DRUGS MARKET FOR RETAIL PHARMACY, BY REGION, 2022-2032 ($MILLION)
TABLE 18. CLOT BUSTING DRUGS MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 19. NORTH AMERICA CLOT BUSTING DRUGS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 20. NORTH AMERICA CLOT BUSTING DRUGS MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 21. NORTH AMERICA CLOT BUSTING DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
TABLE 22. NORTH AMERICA CLOT BUSTING DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 23. NORTH AMERICA CLOT BUSTING DRUGS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 24. U.S. CLOT BUSTING DRUGS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 25. U.S. CLOT BUSTING DRUGS MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 26. U.S. CLOT BUSTING DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
TABLE 27. U.S. CLOT BUSTING DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 28. CANADA CLOT BUSTING DRUGS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 29. CANADA CLOT BUSTING DRUGS MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 30. CANADA CLOT BUSTING DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
TABLE 31. CANADA CLOT BUSTING DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 32. MEXICO CLOT BUSTING DRUGS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 33. MEXICO CLOT BUSTING DRUGS MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 34. MEXICO CLOT BUSTING DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
TABLE 35. MEXICO CLOT BUSTING DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 36. EUROPE CLOT BUSTING DRUGS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 37. EUROPE CLOT BUSTING DRUGS MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 38. EUROPE CLOT BUSTING DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
TABLE 39. EUROPE CLOT BUSTING DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 40. EUROPE CLOT BUSTING DRUGS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 41. GERMANY CLOT BUSTING DRUGS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 42. GERMANY CLOT BUSTING DRUGS MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 43. GERMANY CLOT BUSTING DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
TABLE 44. GERMANY CLOT BUSTING DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 45. UK CLOT BUSTING DRUGS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 46. UK CLOT BUSTING DRUGS MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 47. UK CLOT BUSTING DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
TABLE 48. UK CLOT BUSTING DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 49. FRANCE CLOT BUSTING DRUGS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 50. FRANCE CLOT BUSTING DRUGS MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 51. FRANCE CLOT BUSTING DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
TABLE 52. FRANCE CLOT BUSTING DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 53. SPAIN CLOT BUSTING DRUGS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 54. SPAIN CLOT BUSTING DRUGS MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 55. SPAIN CLOT BUSTING DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
TABLE 56. SPAIN CLOT BUSTING DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 57. ITALY CLOT BUSTING DRUGS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 58. ITALY CLOT BUSTING DRUGS MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 59. ITALY CLOT BUSTING DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
TABLE 60. ITALY CLOT BUSTING DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 61. REST OF EUROPE CLOT BUSTING DRUGS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 62. REST OF EUROPE CLOT BUSTING DRUGS MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 63. REST OF EUROPE CLOT BUSTING DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
TABLE 64. REST OF EUROPE CLOT BUSTING DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 65. ASIA-PACIFIC CLOT BUSTING DRUGS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 66. ASIA-PACIFIC CLOT BUSTING DRUGS MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 67. ASIA-PACIFIC CLOT BUSTING DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
TABLE 68. ASIA-PACIFIC CLOT BUSTING DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 69. ASIA-PACIFIC CLOT BUSTING DRUGS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 70. CHINA CLOT BUSTING DRUGS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 71. CHINA CLOT BUSTING DRUGS MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 72. CHINA CLOT BUSTING DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
TABLE 73. CHINA CLOT BUSTING DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 74. JAPAN CLOT BUSTING DRUGS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 75. JAPAN CLOT BUSTING DRUGS MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 76. JAPAN CLOT BUSTING DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
TABLE 77. JAPAN CLOT BUSTING DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 78. INDIA CLOT BUSTING DRUGS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 79. INDIA CLOT BUSTING DRUGS MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 80. INDIA CLOT BUSTING DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
TABLE 81. INDIA CLOT BUSTING DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 82. SOUTH KOREA CLOT BUSTING DRUGS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 83. SOUTH KOREA CLOT BUSTING DRUGS MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 84. SOUTH KOREA CLOT BUSTING DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
TABLE 85. SOUTH KOREA CLOT BUSTING DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 86. AUSTRALIA CLOT BUSTING DRUGS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 87. AUSTRALIA CLOT BUSTING DRUGS MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 88. AUSTRALIA CLOT BUSTING DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
TABLE 89. AUSTRALIA CLOT BUSTING DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 90. REST OF ASIA-PACIFIC CLOT BUSTING DRUGS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 91. REST OF ASIA-PACIFIC CLOT BUSTING DRUGS MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 92. REST OF ASIA-PACIFIC CLOT BUSTING DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
TABLE 93. REST OF ASIA-PACIFIC CLOT BUSTING DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 94. LAMEA CLOT BUSTING DRUGS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 95. LAMEA CLOT BUSTING DRUGS MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 96. LAMEA CLOT BUSTING DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
TABLE 97. LAMEA CLOT BUSTING DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 98. LAMEA CLOT BUSTING DRUGS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 99. BRAZIL CLOT BUSTING DRUGS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 100. BRAZIL CLOT BUSTING DRUGS MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 101. BRAZIL CLOT BUSTING DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
TABLE 102. BRAZIL CLOT BUSTING DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 103. SAUDI ARABIA CLOT BUSTING DRUGS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 104. SAUDI ARABIA CLOT BUSTING DRUGS MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 105. SAUDI ARABIA CLOT BUSTING DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
TABLE 106. SAUDI ARABIA CLOT BUSTING DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 107. UNITED ARAB EMIRATES CLOT BUSTING DRUGS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 108. UNITED ARAB EMIRATES CLOT BUSTING DRUGS MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 109. UNITED ARAB EMIRATES CLOT BUSTING DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
TABLE 110. UNITED ARAB EMIRATES CLOT BUSTING DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 111. SOUTH AFRICA CLOT BUSTING DRUGS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 112. SOUTH AFRICA CLOT BUSTING DRUGS MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 113. SOUTH AFRICA CLOT BUSTING DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
TABLE 114. SOUTH AFRICA CLOT BUSTING DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 115. REST OF LAMEA CLOT BUSTING DRUGS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 116. REST OF LAMEA CLOT BUSTING DRUGS MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 117. REST OF LAMEA CLOT BUSTING DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2032 ($MILLION)
TABLE 118. REST OF LAMEA CLOT BUSTING DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
TABLE 119. PFIZER INC.: KEY EXECUTIVES
TABLE 120. PFIZER INC.: COMPANY SNAPSHOT
TABLE 121. JOHNSON & JOHNSON SERVICES INC: KEY EXECUTIVES
TABLE 122. JOHNSON & JOHNSON SERVICES INC: COMPANY SNAPSHOT
TABLE 123. SANOFI: KEY EXECUTIVES
TABLE 124. SANOFI: COMPANY SNAPSHOT
TABLE 125. DR. REDDY’S LABORATORIES: KEY EXECUTIVES
TABLE 126. DR. REDDY’S LABORATORIES: COMPANY SNAPSHOT
TABLE 127. BAYER AG: KEY EXECUTIVES
TABLE 128. BAYER AG: COMPANY SNAPSHOT
TABLE 129. BOEHRINGER INGELHEIM GMBH: KEY EXECUTIVES
TABLE 130. BOEHRINGER INGELHEIM GMBH: COMPANY SNAPSHOT
TABLE 131. GENENTECH INC.: KEY EXECUTIVES
TABLE 132. GENENTECH INC.: COMPANY SNAPSHOT
TABLE 133. ELI LILLY AND COMPANY: KEY EXECUTIVES
TABLE 134. ELI LILLY AND COMPANY: COMPANY SNAPSHOT
TABLE 135. SUN PHARMACEUTICAL INDUSTRIES LTD.: KEY EXECUTIVES
TABLE 136. SUN PHARMACEUTICAL INDUSTRIES LTD.: COMPANY SNAPSHOT
TABLE 137. MERCK & CO: KEY EXECUTIVES
TABLE 138. MERCK & CO: COMPANY SNAPSHOT

★調査レポート[世界の血栓溶解薬市場2023年-2032年：製品別（血栓溶解薬、抗血小板薬、抗凝固薬、その他）、疾患別（肺塞栓症、深部静脈血栓症、心房細動、その他）、投与経路別（経口、注射）、流通チャネル別（病院薬局、オンライン薬局、小売薬局）] (コード：ALD23SEP170)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の血栓溶解薬市場2023年-2032年：製品別（血栓溶解薬、抗血小板薬、抗凝固薬、その他）、疾患別（肺塞栓症、深部静脈血栓症、心房細動、その他）、投与経路別（経口、注射）、流通チャネル別（病院薬局、オンライン薬局、小売薬局）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のアテローム性動脈硬化症治療薬市場2023年-2032年：薬剤種類別（抗血小板薬＆抗凝固薬、コレステロール低下薬、ACE阻害薬、その他）、投与経路別（経口、注射）、流通チャネル別（病院薬局、オンラインプロバイダー、ドラッグストア＆小売薬局）
  • 世界のリンパ腫治療薬市場2023年-2032年：疾患種類別（ホジキンリンパ腫、非ホジキンリンパ腫）、治療種類別（免疫療法、化学療法、標的療法、放射線療法）、投与経路別（経口経路、注射）、流通チャネル別（病院薬局、小売薬局、オンライン薬局）
  • 世界の抗肥満薬市場2023年-2032年：薬剤種類別（処方薬、市販薬）、作用機序別（中枢作用性抗肥満薬、末梢作用性抗肥満薬）、投与経路別（経口経路、皮下経路）、流通経路別（病院薬局、小売薬局、オンライン薬局）
  • 世界の動脈硬化治療薬市場2023-2033：薬効分類別（抗血小板薬、コレステロール低下薬、βブロッカー、ACE阻害薬、カルシウム拮抗薬、利尿薬）、流通チャネル別（小売薬局、病院薬局、オンライン薬局）、地域別
  • 世界のジェネリック医薬品市場2023年-2032年：治療用途別（心血管、感染症、がん、糖尿病、その他）、投与経路別（経口、注射、その他）、流通チャネル別（病院薬局、小売薬局、オンラインプロバイダー）
  • 世界の気管支喘息治療市場2023-2033：治療薬別（長期喘息治療薬、即効性喘息治療薬）、投与経路別（吸入、経口、静脈内、皮下）、流通チャネル別（病院薬局、小売薬局、オンライン薬局）
  • 世界の体部白癬治療薬市場2022-2029：薬剤別（抗真菌剤、その他）、投与経路別（経口、局所、非経口）、エンドユーザー別（病院、在宅医療、専門クリニック）、流通チャネル別（病院薬局、オンライン薬局、小売薬局）、地域別
  • 世界のオピオイド使用障害（OUD）治療剤市場2022-2029：薬物クラス別（ブプレノルフィン、メタドン、ナルトレキソン）、投与経路別（経口、非経口）、流通チャネル別（病院薬局、小売薬局＆店舗、オンライン薬局）、地域別
  • 世界の僧帽弁疾患治療薬市場2023年-2032年：薬剤クラス別（ベータ遮断薬、利尿薬、抗凝固薬、その他）、年齢層別（55歳以下、55歳以上）、流通チャネル別（病院薬局、ドラッグストア＆小売薬局、オンラインプロバイダー）
  • 世界のインクレチン系薬剤市場2023年-2032年：薬剤クラス別（GLP-1受容体作動薬、DPP-4阻害薬）、投与経路別（非経口、経口）、流通チャネル別（病院薬局、ドラッグストア・小売薬局、オンラインプロバイダー）

    • ◆H&Iグローバルリサーチのお客様（例）◆